Global anaphylaxis market to reach $5.14B by 2030 at 7.9% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Anaphylaxis Market Expected To Reach Based On Its 2026 Value?

The anaphylaxis market size has seen strong expansion in recent years. It is forecast to rise from $3.5 billion in 2025 to $3.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to a heightened incidence of food and drug allergies, more frequent diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, increasing public health awareness, and the adoption of consistent treatment guidelines.

The market for anaphylaxis treatments is projected to experience robust expansion in the coming years. This market is forecast to reach $5.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the projection period include improved access to urgent allergy care, an increased need for portable treatment options, the broadening of allergy specialty services, a heightened emphasis on patient education initiatives, and greater investment in allergy management systems. Key trends anticipated over the forecast timeframe involve the wider availability of epinephrine auto-injectors, a heightened understanding of severe allergic responses, an increased focus on readiness for emergencies, the advancement of allergy diagnosis and monitoring, and an improved emphasis on swift intervention protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

What Primary Drivers Are Shaping The Anaphylaxis Market?

The increasing incidence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the coming period. Food allergies manifest as immune responses provoked by specific food items, leading to symptoms ranging from minor to critical, such as severe anaphylaxis, which can be fatal. This growing occurrence of food allergies stems from elements like evolving dietary patterns, environmental factors, and enhanced diagnostic capabilities and public awareness. Anaphylaxis treatment offers essential, life-saving care for individuals with food allergies by quickly mitigating severe allergic responses; it alleviates symptoms like swelling, respiratory distress, and decreased blood pressure, ensuring prompt stabilization and averting potentially deadly results, concurrently equipping patients to act swiftly during subsequent allergic episodes. For example, data from September 2024, released by the World Health Organization (WHO), a Switzerland-based United Nations (UN) entity, indicates that approximately 220 million individuals worldwide suffer from food allergies. A sole food item might contain various allergens, and people can be sensitive to more than one kind of food. Furthermore, the Patterns and Prevalence of Adult Food Allergy (PAFA) report from May 2024, issued by the Food Standards Agency (FSA), a UK-based non-ministerial department, stated that more than 30% of adults reported adverse reactions linked to food, with clinical evaluations confirming food allergies in about 6% of UK adults, which amounts to around 2.4 million individuals. Consequently, the increasing prevalence of food allergies is propelling the expansion of the anaphylaxis market.

How Are Segments Identified Within The Anaphylaxis Market Segment Framework?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What Trends Are Affecting The Growth Of The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are focusing on developing advanced epinephrine nasal sprays, which enable faster, more efficient drug delivery during emergencies. An epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) was approved by the Food and Drug Administration, a US-based government agency, marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

Who Are The Companies Competing Within The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Get The Full Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Represents The Largest Share Of The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anaphylaxis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

Allergic Rhinitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Inhalable Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795